Can Modern's COVID 19 Vaccine Generate Lasting Immunity?

Dr. Patrick Soon-Shiong, Chairman and CEO of ImmunityBio, explains why T-cell immunity could be an important metric when evaluating experimental COVID-19 vaccines.